Latest News about XENE
Recent news which mentions XENE
From Benzinga
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
From Benzinga
Earnings Scheduled For May 10, 2022
May 10, 2022
From Benzinga
Xenon Pharmaceuticals's Return On Capital Employed Overview
March 07, 2022
Tickers
XENE
From Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
From Benzinga
From Benzinga
Wednesdays With Wedbush: Analyst Laura Chico On The State Of Biotech
December 29, 2021
From Benzinga
Xenon Stock Jumps On New Encouraging Data From Epilepsy Treatment
December 03, 2021
Tickers
XENE
From Benzinga
The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering
December 03, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
November 28, 2021
From Benzinga
Xenon Pharmaceuticals Has a Great Story But Too High a Price
October 29, 2021
Tickers
XENE
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021
October 28, 2021
From Benzinga
Xenon: Heading Toward Phase III With Strong Momentum
October 26, 2021
From InvestorPlace
New Clinical Results Make Xenon Pharmaceuticals’ Stock Worthy Again
October 19, 2021
Tickers
XENE
From InvestorPlace
3 Growth Stocks Near 52-Week Highs to Buy Anyway
October 14, 2021
From Motley Fool
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
October 10, 2021
From Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
October 06, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.